Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences, Inc. (RNA) Prepaid Assets (2019 - 2025)

Avidity Biosciences' Prepaid Assets history spans 7 years, with the latest figure at $101.6 million for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 441.13% year-over-year to $101.6 million; the TTM value through Dec 2025 reached $101.6 million, up 441.13%, while the annual FY2025 figure was $101.6 million, 441.13% up from the prior year.
  • Prepaid Assets reached $101.6 million in Q4 2025 per RNA's latest filing, up from $60.0 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $101.6 million in Q4 2025 to a low of $4.0 million in Q1 2021.
  • Average Prepaid Assets over 5 years is $25.2 million, with a median of $14.4 million recorded in 2023.
  • Peak YoY movement for Prepaid Assets: soared 472.65% in 2021, then fell 23.16% in 2022.
  • A 5-year view of Prepaid Assets shows it stood at $5.6 million in 2021, then skyrocketed by 118.2% to $12.2 million in 2022, then soared by 30.63% to $16.0 million in 2023, then grew by 17.67% to $18.8 million in 2024, then surged by 441.13% to $101.6 million in 2025.
  • Per Business Quant, the three most recent readings for RNA's Prepaid Assets are $101.6 million (Q4 2025), $60.0 million (Q3 2025), and $67.4 million (Q2 2025).